Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06977100 · ClinicalTrials.gov registry record · NA
Journaling Intervention for Temporomandibular Disorder (TMD) and Chronic Overlapping Pain
A NA study of Temporomandibular Disorders (TMD), sponsored by University of Florida.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT06977100: Recruiting NA study of Temporomandibular Disorders (TMD), sponsored by University of Florida.
NCT06977100 is a NA study of Temporomandibular Disorders (TMD) that is actively recruiting participants, run by University of Florida. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06977100, a NA study of Temporomandibular Disorders (TMD), is actively recruiting participants, sponsored by University of Florida.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to learn whether a 2-week gratitude journaling activity is feasible and acceptable for individuals with Temporomandibular Disorder (TMD) and chronic overlapping pain. The study will also look at whether this activity is helpful in reducing pain and how much it interferes with daily life. The primary aims of this study are to: * Assess whether individuals with TMD and chronic overlapping pain are able to complete the 2-week gratitude journaling activity as planned (feasibility). * Evaluate how acceptable participants find the gratitude journaling activity (acceptability). The secondary aim of this study is to: • Explore whether the gratitude journaling activity reduces pain and its impact on daily life, compared to a general wellness journaling activity. Participants will: * Attend two in-person visits to complete questionnaires and take part in tests that measure how sensitive they are to pressure and heat. * Complete a 2-week journaling activity at home, writing in their journal on three days of their choice per week.
Primary Outcome
Percentage of participants who initiate treatment/intervention and complete the post-intervention assessment at the 4-week time-point.
Conditions Studied
Interventions
- BEHAVIORAL Gratitude
- OTHER General Wellness
Study Locations (1)
Florida
- University of Florida - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2025-08-11 |
| Est. Completion | 2026-12 |
| Phase | NA |
What NCT06977100 shows while recruiting
NCT06977100 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Temporomandibular Disorders (TMD) appearing as the primary indexed condition, and to 2 interventions - of which Gratitude is the first listed.
NCT06977100 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT06977100 about?
NCT06977100 is a clinical study titled "Journaling Intervention for Temporomandibular Disorder (TMD) and Chronic Overlapping Pain". The goal of this clinical trial is to learn whether a 2-week gratitude journaling activity is feasible and acceptable for individuals with Temporomandibular Disorder (TMD) and chronic overlapping pain. The study will also look at whether this activity is helpful in reducing pain and how much it inte...
What is the current status of trial NCT06977100?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-08-11. Estimated completion is 2026-12.
What conditions does trial NCT06977100 study?
This clinical trial studies the following conditions: Temporomandibular Disorders (TMD).
What interventions are being tested in trial NCT06977100?
The interventions under investigation include: Gratitude (BEHAVIORAL), General Wellness (OTHER).
Who is sponsoring clinical trial NCT06977100?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06977100 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Temporomandibular Disorders (TMD)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06977100's enrollment target sits among peer trials
60 1165th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI